Neurotech International Limited (ASX:NTI)
0.0180
+0.0010 (5.88%)
Nov 6, 2025, 3:24 PM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 18.89 million as of November 6, 2025. Its market cap has decreased by -61.96% in one year.
Market Cap
18.89M
Enterprise Value
15.86M
Revenue
2.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 18.89M, a decrease of -24.70%. That is a compound annual growth rate of -3.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 17.84M | -68.87% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | 25.25M | 1,062.42% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.54B |
| Pro Medicus | 26.99B |
| Cochlear | 18.36B |
| Sonic Healthcare | 10.27B |
| Ramsay Health Care | 7.22B |
| Telix Pharmaceuticals | 5.33B |
| Ansell | 5.16B |
| Mesoblast | 3.09B |